• Summary
  • Table Of Content
  • Segmentation
  • Request sample

Topical Corticosteroids Market Synopsis:

Topical Corticosteroids Market Size Was Valued at USD 4.2 Billion in 2023, and is Projected to Reach USD 6.1 Billion by 2032, Growing at a CAGR of 4.3% From 2024-2032.

Topical corticosteroids or TCS are a class of drugs that is used mostly for the management of inflammatory dermatoses. They include eczema, psoriasis, dermatitis, allergic dermatitis, and dermal reactions as well as other skin related complaints. These drugs are topical agents that are used in treating affected skin to minimize inflammation, skin redness and irritation. There are many formulations in topical corticosteroids: creams, ointments, lotions and gels depending on the nature and area of the skin disease. Such drugs come as mild and potent which defines the levels of intensity for inflammation where the drugs would be most effective. TCS may be applied selectively, thus avoiding side effects common to systemic oral corticosteroids and serve as the mainstay in the management of cutaneous disorders with various etiology. Skin aliments that were rare a few years ago are common today This coupled with a steady rise in awareness among people about skin related health issues coupled with enhanced formulation offers a good market for topical steroids.

Topical corticosteroids’ market has been growing in the global over the years, due to the increase in skin disorders particularly among the geriatric population base. Chronic skin conditions like eczema, psoriasis, and rosacea have become more common globally, and therefore, there is an ever increasing need for appropriate therapies. This is boosted by innovation in formulation technology to produce products which are effective in usage but have little or no side effects. Related to this, increased usage of topical corticosteroids has played a major role in increasing the market size, due to easier accessibility of both prescription and over-the-counter products.

Another driving force is the appreciable enhancement in the healthcare consciousness of people across the world that are more inclined toward seeking dermatological consultation regarding the skin and are more likely to prefer the topical corticosteroids. The dynamic development in the pharmaceutical industry has ensured that the new formulations exist and the drug delivery systems enhance therapeutic efficacy. Moreover, with the enhancement of the health care set up in the global emerging markets, the utilization of topical corticosteroids is likely to rise and in turn help to boost the global market. Fifth, other factors which are extremely important in determining the future course of the market include the fact that the products are produced by companies with strong brands and the fact that the companies have expanded their distribution channels.

Topical Corticosteroids Market - Trend, Growth, Forecast 2024–2032

Topical Corticosteroids Market Trend Analysis:

Increasing Preference for Combination Therapies in Topical Corticosteroids

  • Another identified topical corticosteroids market trend is the shift towards using combined therapies. To improve the efficacy and practicability of the treatment, a large number of products are being designed whereby the corticosteroid is formulated with other active substances, including antibiotics, antifungals, or emollients. These combination products offer two broad advantages of anti-inflammatory relief and treatment of the causative factors of the skin condition namely bacterial or viral. Combined therapies also eliminate the use of frequent application, thus making the therapies more favorable among patients. For this reason, they are becoming good steady among the health care providers and the patient, particularly in the management of conditions that are frequently persistent or complicated in nature. The former is seen to continue influencing the market for topical corticosteroids since combination therapies are likely to lead to better therapeutic benefits and increased patient satisfaction.

Expanding Market in Emerging Economies

  • The increase in healthcare consciousness and the availability of treatments in the emerging markets further produced as a great prospect for the market of topical corticosteroids. Asia-Pacific, Latin America, and the Middle Eastern countries are emerging as economically developing nations where urbanization is on the rise, as a result of which there are focused on on health care foundation. As the general public gets better access to health care facilities then dermatological care then the need for safe efficient and effective procedures for skin disorders becomes paramount. Such areas are now using topical corticosteroids for treatment of conditions such as eczema, dermatitis, as well as psoriasis. Moreover, rising disposal incomes in household and the use of self-medication are the major factors developing a conducive growth environment for the market. Correspondingly, it is expected that pharmaceutical companies will extend up their portfolios and networks of offices in these regions.

Topical Corticosteroids Market Segment Analysis:

Topical Corticosteroids Market Segmented on the basis of Formulation, Application, Distribution Channel, and Region.

By Formulation, Creams segment is expected to dominate the market during the forecast period

  • The creams segment is expected to maintain its position as the largest segment in the topical corticosteroids market throughout the forecast period because of the product’s flexibility and efficacy. Creams are favoured for managing severities of skin disorders because their mean water content and corticosteroids activity are optimal. In contrast to ointments that feel greasy and uncomfortable on the skin surface for some persons the creams are light in nature, have no greasy feeling and is easily spread hence more acceptable among the patient base. There is indication that the user base for creams is set to grow, especially for managing chronic inflammatory skin conditions as more patients are expected to need long-term therapies treatments.

By Application, Acne segment expected to held the largest share

  • Out of all the uses of topical corticosteroids, the acne market is projected to lead the report’s segmented breakdown thanks to such factors as the increasing number of people suffering from acne, especially teenagers and young people. Skin acne is one of the most widespread skin diseases affecting millions of people globally and in turn, people searching for the best way of handling the skin problem. Topical corticosteroids are commonly used together with other therapies to help manage inflammation, and decrease the number of lesions that occur. Higher awareness about acne management and presence of essentially different, over the counter topical corticosteroid products for acne treatment are anticipated to foster the growth of this segment.

Topical Corticosteroids Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • It is also expected that in North America this market will take the largest share of the total global market in the next years, particularly in 2023, with the United States leading the demand for topical corticosteroids. Diseases of the skin are common in this region and North America benefits from well developed healthcare facilities putting it ahead as the largest consumer of topical corticosteroids in the market. Eczema, psoriasis, and acne are common skin conditions in the United States, and the need for treatments for these conditions grows year on year. In addition, growth of major pharmaceutical players and superior distribution infrastructure provides the region advantage. North America will constituted a significant market share in 2023 and accounts for nearly 40-45% of global sales of both prescription and over the counter products focusing a laundry list of dermatological issues.

Active Key Players in the Topical Corticosteroids Market:

  • AbbVie Inc. (USA)
  • Amgen Inc. (USA)
  • Bayer AG (Germany)
  • Bristol-Myers Squibb (USA)
  • Cipla Limited (India)
  • GlaxoSmithKline plc (UK)
  • Johnson & Johnson (USA)
  • Mylan N.V. (USA)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (USA)
  • Sanofi S.A. (France)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Taro Pharmaceutical Industries Ltd. (Israel)
  • Viatris Inc. (USA)
  • Zydus Cadila (India)
  • Other Active Players

Topical Corticosteroids Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 4.2 Billion

Forecast Period 2024-32 CAGR:

 4.3%

Market Size in 2032:

USD 6.1 Billion

Segments Covered:

By Formulation

  • Creams
  • Ointments
  • Gels
  • Others

By Application

  • Acne
  • Dermatitis
  • Psoriasis
  • Eczema
  • Hyperpigmentation
  • Others (rash, etc.)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing prevalence of dermatological disorders, including eczema, psoriasis, and acne

Key Market Restraints:

  • The potential for side effects associated with long-term use of corticosteroids

Key Opportunities:

  • The growing demand for combination therapies

Companies Covered in the report:

  • AbbVie Inc. (USA), Amgen Inc. (USA), Bayer AG (Germany), Bristol-Myers Squibb (USA), Cipla Limited (India), GlaxoSmithKline plc (UK), Johnson & Johnson (USA), Mylan N.V. (USA) and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Topical Corticosteroids Market by Formulation
 4.1 Topical Corticosteroids Market Snapshot and Growth Engine
 4.2 Topical Corticosteroids Market Overview
 4.3 Creams
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Creams: Geographic Segmentation Analysis
 4.4 Ointments
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Ointments: Geographic Segmentation Analysis
 4.5 Gels
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Gels: Geographic Segmentation Analysis
 4.6 Others (solutions
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Others (solutions: Geographic Segmentation Analysis
 4.7 foams
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 foams: Geographic Segmentation Analysis
 4.8 spray
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 spray: Geographic Segmentation Analysis
 4.9 etc.)
  4.9.1 Introduction and Market Overview
  4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.9.3 Key Market Trends, Growth Factors and Opportunities
  4.9.4 etc.): Geographic Segmentation Analysis

Chapter 5: Topical Corticosteroids Market by Application
 5.1 Topical Corticosteroids Market Snapshot and Growth Engine
 5.2 Topical Corticosteroids Market Overview
 5.3 Acne
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Acne: Geographic Segmentation Analysis
 5.4 Dermatitis
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Dermatitis: Geographic Segmentation Analysis
 5.5 Psoriasis
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Psoriasis: Geographic Segmentation Analysis
 5.6 Eczema
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Eczema: Geographic Segmentation Analysis
 5.7 Hyperpigmentation
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Hyperpigmentation: Geographic Segmentation Analysis
 5.8 Others (rash
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Others (rash: Geographic Segmentation Analysis
 5.9 etc.)
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 etc.): Geographic Segmentation Analysis

Chapter 6: Topical Corticosteroids Market by Distribution Channel
 6.1 Topical Corticosteroids Market Snapshot and Growth Engine
 6.2 Topical Corticosteroids Market Overview
 6.3 Hospital Pharmacies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospital Pharmacies: Geographic Segmentation Analysis
 6.4 Retail Pharmacies
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Retail Pharmacies: Geographic Segmentation Analysis
 6.5 Online Pharmacies
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Online Pharmacies: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Topical Corticosteroids Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions  
 7.2 ABBVIE INC. (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 AMGEN INC. (USA)
 7.4 BAYER AG (GERMANY)
 7.5 BRISTOL-MYERS SQUIBB (USA)
 7.6 CIPLA LIMITED (INDIA)
 7.7 GLAXOSMITHKLINE PLC (UK)
 7.8 JOHNSON & JOHNSON (USA)
 7.9 MYLAN N.V. (USA)
 7.10 NOVARTIS AG (SWITZERLAND)
 7.11 PFIZER INC. (USA)
 7.12 SANOFI S.A. (FRANCE)
 7.13 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
 7.14 TARO PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
 7.15 VIATRIS INC. (USA)
 7.16 ZYDUS CADILA (INDIA)
 7.17 OTHER ACTIVE PLAYERS

Chapter 8: Global Topical Corticosteroids Market By Region
 8.1 Overview
8.2. North America Topical Corticosteroids Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Formulation
  8.2.4.1 Creams
  8.2.4.2 Ointments
  8.2.4.3 Gels
  8.2.4.4 Others (solutions
  8.2.4.5 foams
  8.2.4.6 spray
  8.2.4.7 etc.)
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Acne
  8.2.5.2 Dermatitis
  8.2.5.3 Psoriasis
  8.2.5.4 Eczema
  8.2.5.5 Hyperpigmentation
  8.2.5.6 Others (rash
  8.2.5.7 etc.)
  8.2.6 Historic and Forecasted Market Size By Distribution Channel
  8.2.6.1 Hospital Pharmacies
  8.2.6.2 Retail Pharmacies
  8.2.6.3 Online Pharmacies
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
8.3. Eastern Europe Topical Corticosteroids Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Formulation
  8.3.4.1 Creams
  8.3.4.2 Ointments
  8.3.4.3 Gels
  8.3.4.4 Others (solutions
  8.3.4.5 foams
  8.3.4.6 spray
  8.3.4.7 etc.)
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Acne
  8.3.5.2 Dermatitis
  8.3.5.3 Psoriasis
  8.3.5.4 Eczema
  8.3.5.5 Hyperpigmentation
  8.3.5.6 Others (rash
  8.3.5.7 etc.)
  8.3.6 Historic and Forecasted Market Size By Distribution Channel
  8.3.6.1 Hospital Pharmacies
  8.3.6.2 Retail Pharmacies
  8.3.6.3 Online Pharmacies
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Russia
  8.3.7.2 Bulgaria
  8.3.7.3 The Czech Republic
  8.3.7.4 Hungary
  8.3.7.5 Poland
  8.3.7.6 Romania
  8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Topical Corticosteroids Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Formulation
  8.4.4.1 Creams
  8.4.4.2 Ointments
  8.4.4.3 Gels
  8.4.4.4 Others (solutions
  8.4.4.5 foams
  8.4.4.6 spray
  8.4.4.7 etc.)
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Acne
  8.4.5.2 Dermatitis
  8.4.5.3 Psoriasis
  8.4.5.4 Eczema
  8.4.5.5 Hyperpigmentation
  8.4.5.6 Others (rash
  8.4.5.7 etc.)
  8.4.6 Historic and Forecasted Market Size By Distribution Channel
  8.4.6.1 Hospital Pharmacies
  8.4.6.2 Retail Pharmacies
  8.4.6.3 Online Pharmacies
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 The Netherlands
  8.4.7.5 Italy
  8.4.7.6 Spain
  8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Topical Corticosteroids Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Formulation
  8.5.4.1 Creams
  8.5.4.2 Ointments
  8.5.4.3 Gels
  8.5.4.4 Others (solutions
  8.5.4.5 foams
  8.5.4.6 spray
  8.5.4.7 etc.)
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Acne
  8.5.5.2 Dermatitis
  8.5.5.3 Psoriasis
  8.5.5.4 Eczema
  8.5.5.5 Hyperpigmentation
  8.5.5.6 Others (rash
  8.5.5.7 etc.)
  8.5.6 Historic and Forecasted Market Size By Distribution Channel
  8.5.6.1 Hospital Pharmacies
  8.5.6.2 Retail Pharmacies
  8.5.6.3 Online Pharmacies
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
8.6. Middle East & Africa Topical Corticosteroids Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Formulation
  8.6.4.1 Creams
  8.6.4.2 Ointments
  8.6.4.3 Gels
  8.6.4.4 Others (solutions
  8.6.4.5 foams
  8.6.4.6 spray
  8.6.4.7 etc.)
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Acne
  8.6.5.2 Dermatitis
  8.6.5.3 Psoriasis
  8.6.5.4 Eczema
  8.6.5.5 Hyperpigmentation
  8.6.5.6 Others (rash
  8.6.5.7 etc.)
  8.6.6 Historic and Forecasted Market Size By Distribution Channel
  8.6.6.1 Hospital Pharmacies
  8.6.6.2 Retail Pharmacies
  8.6.6.3 Online Pharmacies
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkiye
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
8.7. South America Topical Corticosteroids Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Formulation
  8.7.4.1 Creams
  8.7.4.2 Ointments
  8.7.4.3 Gels
  8.7.4.4 Others (solutions
  8.7.4.5 foams
  8.7.4.6 spray
  8.7.4.7 etc.)
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Acne
  8.7.5.2 Dermatitis
  8.7.5.3 Psoriasis
  8.7.5.4 Eczema
  8.7.5.5 Hyperpigmentation
  8.7.5.6 Others (rash
  8.7.5.7 etc.)
  8.7.6 Historic and Forecasted Market Size By Distribution Channel
  8.7.6.1 Hospital Pharmacies
  8.7.6.2 Retail Pharmacies
  8.7.6.3 Online Pharmacies
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
 

Topical Corticosteroids Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 4.2 Billion

Forecast Period 2024-32 CAGR:

 4.3%

Market Size in 2032:

USD 6.1 Billion

Segments Covered:

By Formulation

  • Creams
  • Ointments
  • Gels
  • Others

By Application

  • Acne
  • Dermatitis
  • Psoriasis
  • Eczema
  • Hyperpigmentation
  • Others (rash, etc.)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing prevalence of dermatological disorders, including eczema, psoriasis, and acne

Key Market Restraints:

  • The potential for side effects associated with long-term use of corticosteroids

Key Opportunities:

  • The growing demand for combination therapies

Companies Covered in the report:

  • AbbVie Inc. (USA), Amgen Inc. (USA), Bayer AG (Germany), Bristol-Myers Squibb (USA), Cipla Limited (India), GlaxoSmithKline plc (UK), Johnson & Johnson (USA), Mylan N.V. (USA) and Other Active Players.
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Topical Corticosteroids Market research report?

The forecast period in the Topical Corticosteroids Market research report is 2024-2032.

Who are the key players in the Topical Corticosteroids Market?

AbbVie Inc. (USA), Amgen Inc. (USA), Bayer AG (Germany), Bristol-Myers Squibb (USA), Cipla Limited (India), GlaxoSmithKline plc (UK), Johnson & Johnson (USA), Mylan N.V. (USA), Novartis AG (Switzerland), Pfizer Inc. (USA), Sanofi S.A. (France), Teva Pharmaceutical Industries Ltd. (Israel), Taro Pharmaceutical Industries Ltd. (Israel), Viatris Inc. (USA), Zydus Cadila (India), Other Active Players.

What are the segments of the Topical Corticosteroids Market?

The Topical Corticosteroids Market is segmented into Formulation, Application, Distribution Channel and region. By Formulation, the market is categorized into Creams, Ointments, Gels, Others (solutions, foams, spray, etc.). By Application, the market is categorized into Acne, Dermatitis, Psoriasis, Eczema, Hyperpigmentation, Others (rash, etc.). By Distribution Channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC),Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).

What is the Topical Corticosteroids Market?

Topical corticosteroids or TCS are a class of drugs that is used mostly for the management of inflammatory dermatoses. They include eczema, psoriasis, dermatitis, allergic dermatitis, and dermal reactions as well as other skin related complaints. These drugs are topical agents that are used in treating affected skin to minimize inflammation, skin redness and irritation. There are many formulations in topical corticosteroids: creams, ointments, lotions and gels depending on the nature and area of the skin disease. Such drugs come as mild and potent which defines the levels of intensity for inflammation where the drugs would be most effective. TCS may be applied selectively, thus avoiding side effects common to systemic oral corticosteroids and serve as the mainstay in the management of cutaneous disorders with various etiology. Skin aliments that were rare a few years ago are common today This coupled with a steady rise in awareness among people about skin related health issues coupled with enhanced formulation offers a good market for topical steroids.

How big is the Topical Corticosteroids Market?

Topical Corticosteroids Market Size Was Valued at USD 4.2 Billion in 2023, and is Projected to Reach USD 6.1 Billion by 2032, Growing at a CAGR of 4.3% From 2024-2032.